{"id":"https://openalex.org/W4292466554","doi":"https://doi.org/10.3389/fphar.2022.901559","title":"Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway","display_name":"Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K/AKT/mTOR Signaling Pathway","alternate_titles":[],"publication_year":2022,"publication_date":"2022-08-10","ids":{"openalex":"https://openalex.org/W4292466554","doi":"https://doi.org/10.3389/fphar.2022.901559","pmid":"https://pubmed.ncbi.nlm.nih.gov/36034798","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9399678"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2022.901559","doi":"https://doi.org/10.3389/fphar.2022.901559","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.901559","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4292466554"],"child_works_count":10,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fphar.2022.901559","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001676122","display_name":"Guoxiang Tong","orcid":"https://orcid.org/0000-0002-8844-9261","observed_orcids":["https://orcid.org/0000-0002-8844-9261"]},"institutions":[{"id":"https://openalex.org/I165911609","display_name":"Changsha Medical University","ror":"https://ror.org/05dt7z971","country_code":"CN","type":"education","lineage":["https://openalex.org/I165911609"]},{"id":"https://openalex.org/I4210111263","display_name":"The First Hospital of Changsha","ror":"https://ror.org/01sy5t684","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111263"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guoxiang Tong","raw_affiliation_strings":["Academician Workstation, Changsha Medical University, Changsha, China","Department of Endocrinology, The First Affiliated Hospital of Changsha Medical University, Changsha, China","Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academician Workstation, Changsha Medical University, Changsha, China","institution_ids":["https://openalex.org/I165911609"]},{"raw_affiliation_string":"Department of Endocrinology, The First Affiliated Hospital of Changsha Medical University, Changsha, China","institution_ids":["https://openalex.org/I165911609","https://openalex.org/I4210111263"]},{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102291228","display_name":"Tianhao Peng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tianhao Peng","raw_affiliation_strings":["Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100762743","display_name":"Ya Chen","orcid":"https://orcid.org/0009-0001-8199-2704","observed_orcids":["https://orcid.org/0009-0001-8199-2704"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ya Chen","raw_affiliation_strings":["Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lijuan Sha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lijuan Sha","raw_affiliation_strings":["Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017525200","display_name":"Huikang Dai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huikang Dai","raw_affiliation_strings":["Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yidong Xiang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yidong Xiang","raw_affiliation_strings":["Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zhiqi Zou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiqi Zou","raw_affiliation_strings":["Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hunan Evidence-based Biotechnology Co., Ltd., Changsha, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033301878","display_name":"Heli He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165911609","display_name":"Changsha Medical University","ror":"https://ror.org/05dt7z971","country_code":"CN","type":"education","lineage":["https://openalex.org/I165911609"]},{"id":"https://openalex.org/I4210111263","display_name":"The First Hospital of Changsha","ror":"https://ror.org/01sy5t684","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111263"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Heli He","raw_affiliation_strings":["Department of Oncology, The First Affiliated Hospital of Changsha Medical University, Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, The First Affiliated Hospital of Changsha Medical University, Changsha, China","institution_ids":["https://openalex.org/I165911609","https://openalex.org/I4210111263"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100608374","display_name":"Sha Wang","orcid":"https://orcid.org/0000-0002-3945-2763","observed_orcids":["https://orcid.org/0000-0002-3945-2763"]},"institutions":[{"id":"https://openalex.org/I165911609","display_name":"Changsha Medical University","ror":"https://ror.org/05dt7z971","country_code":"CN","type":"education","lineage":["https://openalex.org/I165911609"]},{"id":"https://openalex.org/I4210111263","display_name":"The First Hospital of Changsha","ror":"https://ror.org/01sy5t684","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210111263"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Sha Wang","raw_affiliation_strings":["Academician Workstation, Changsha Medical University, Changsha, China","Department of Endocrinology, The First Affiliated Hospital of Changsha Medical University, Changsha, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academician Workstation, Changsha Medical University, Changsha, China","institution_ids":["https://openalex.org/I165911609"]},{"raw_affiliation_string":"Department of Endocrinology, The First Affiliated Hospital of Changsha Medical University, Changsha, China","institution_ids":["https://openalex.org/I165911609","https://openalex.org/I4210111263"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100608374"],"corresponding_institution_ids":["https://openalex.org/I165911609","https://openalex.org/I4210111263"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":9.1857,"has_fulltext":true,"cited_by_count":248,"citation_normalized_percentile":{"value":0.99227728,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"13","issue":null,"first_page":"901559","last_page":"901559"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9223999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9223999977111816,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0551999993622303,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9490000009536743},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.828000009059906},{"id":"https://openalex.org/keywords/cell-invasion","display_name":"cell invasion","score":0.8769999742507935},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/combination-targeted-therapy","display_name":"combination targeted therapy","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.869562566280365},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.7197785377502441},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5992307066917419},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.581180989742279},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5411763191223145},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5275763273239136},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5012531280517578},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46009203791618347},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.45963340997695923},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.44851261377334595},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4014112055301666},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.39969402551651},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33396804332733154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32872241735458374},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2538646459579468},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20479115843772888},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.12273386120796204},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.09697070717811584},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.06472000479698181},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2022.901559","doi":"https://doi.org/10.3389/fphar.2022.901559","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.901559","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9399678","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9399678/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9399678/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:36034798","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36034798","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:055cfd3c79164da88623a77536bdbe9c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/055cfd3c79164da88623a77536bdbe9c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 13 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2022.901559","doi":"https://doi.org/10.3389/fphar.2022.901559","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2022.901559","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4292466554.pdf","grobid_xml":"https://content.openalex.org/works/W4292466554.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W2025634024","https://openalex.org/W2049717993","https://openalex.org/W2114866762","https://openalex.org/W2541955529","https://openalex.org/W2589082299","https://openalex.org/W2613115487","https://openalex.org/W2741196883","https://openalex.org/W2790044111","https://openalex.org/W2801752339","https://openalex.org/W2828406404","https://openalex.org/W2914048721","https://openalex.org/W2916797108","https://openalex.org/W2959708126","https://openalex.org/W2988467244","https://openalex.org/W3003762618","https://openalex.org/W3047956076","https://openalex.org/W3079320437","https://openalex.org/W3080087062","https://openalex.org/W3085470020","https://openalex.org/W3087341260","https://openalex.org/W3133834111","https://openalex.org/W3135289686","https://openalex.org/W3146674090","https://openalex.org/W3151181350","https://openalex.org/W3153125295","https://openalex.org/W3153289786","https://openalex.org/W3153625864","https://openalex.org/W3154376301","https://openalex.org/W3158832711","https://openalex.org/W3159831114","https://openalex.org/W3163449976","https://openalex.org/W4206941655","https://openalex.org/W4207035779","https://openalex.org/W4213393761"],"related_works":["https://openalex.org/W4322183880","https://openalex.org/W7129391294","https://openalex.org/W3020877946","https://openalex.org/W4412522811","https://openalex.org/W3016018555","https://openalex.org/W2578248437","https://openalex.org/W4392661434","https://openalex.org/W4229032689","https://openalex.org/W2951206054","https://openalex.org/W2030866834"],"abstract_inverted_index":{"Colorectal":[0],"cancer":[1],"(CRC)":[2],"has":[3,104],"become":[4],"one":[5],"of":[6,23,30,40,50,63,72,98,111,138,168],"the":[7,21,31,38,48,54,60,66,70,91,109,125,131,141,166,184,199],"top":[8],"ten":[9],"malignant":[10],"tumors":[11],"with":[12,95,130],"a":[13,24,178],"high":[14],"incidence":[15],"rate":[16],"and":[17,53,81,128,145,152,163,165,171,192,194],"mortality.":[18],"Due":[19],"to":[20,77,117],"lack":[22],"good":[25],"CRC":[26,32,51,119,146,185],"screening":[27],"program,":[28],"most":[29],"patients":[33,64],"are":[34,154],"being":[35],"transferred":[36],"at":[37,124],"time":[39],"treatment.":[41],"The":[42,136,173],"conventional":[43],"treatment":[44,94,110],"cannot":[45],"effectively":[46],"improve":[47],"prognosis":[49],"patients,":[52],"target":[55],"drugs":[56],"can":[57],"significantly":[58],"prolong":[59],"overall":[61],"survival":[62],"in":[65,122],"advanced":[67],"stage.":[68],"However,":[69],"use":[71],"single":[73,99],"drug":[74,79,88,101],"may":[75],"lead":[76],"acquired":[78],"resistance":[80],"various":[82],"serious":[83],"complications.":[84],"Therefore,":[85,113],"combined":[86],"targeted":[87,100],"therapy":[89],"is":[90],"main":[92],"alternative":[93],"poor":[96],"effect":[97],"therapy,":[102],"which":[103],"important":[105],"research":[106],"significance":[107],"for":[108],"CRC.":[112],"this":[114],"study":[115],"intends":[116],"culture":[118],"cell":[120,126,147,158,186,189],"lines":[121],"vitro":[123],"level":[127],"intervene":[129],"GLP-1":[132,179],"receptor":[133,180],"agonist":[134],"liraglutide.":[135],"effects":[137],"liraglutide":[139],"on":[140],"PI3K/Akt/mTOR":[142,200],"signal":[143,201],"pathway":[144],"proliferation,":[148,159,190],"cycle,":[149,160,187],"migration,":[150,161,191],"invasion,":[151,162],"apoptosis":[153,164,196],"explored":[155],"by":[156,197],"detecting":[157],"expression":[167],"related":[169],"mRNA":[170],"protein.":[172],"results":[174],"showed":[175],"that":[176],"liraglutide,":[177],"agonist,":[181],"could":[182],"block":[183],"reduce":[188],"invasion":[193],"promote":[195],"inhibiting":[198],"pathway.":[202]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4292466554","counts_by_year":[{"year":2026,"cited_by_count":113},{"year":2025,"cited_by_count":108},{"year":2024,"cited_by_count":22},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2022-08-21T00:00:00"}
